{"entity":{"type":"insider","cik":"0001693530","url":"/insider/0001693530","json_url":"/insider/0001693530.json","name":"Longsworth Todd Christopher","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":57,"n_filings":17,"first":"2018-01-31","last":"2022-03-09","span_basis":"filed_date"},"name_variants":[{"name":"Longsworth Todd Christopher","source":"filing","n_filings":17,"first_seen":"2018-01-31","last_seen":"2022-03-09"}],"transactions":[{"id":6334582,"accession":"0001645113-22-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000025","line_url":"/filing/0001645113-22-000025#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2339.0,"shares_display":"2,339","price_per_share":70.1,"price_display":"70.10","price_state":"stated","total_value":163963.9,"total_display":"163,963.90","shares_owned_after":62462.0,"shares_owned_after_display":"62,462","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-08","filed_date":"2022-03-09","scope":"insider"},{"id":6190575,"accession":"0001645113-22-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-22-000023","line_url":"/filing/0001645113-22-000023#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1973.0,"shares_display":"1,973","price_per_share":70.407,"price_display":"70.41","price_state":"stated","total_value":138913.011,"total_display":"138,913.01","shares_owned_after":64801.0,"shares_owned_after_display":"64,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-04","filed_date":"2022-03-07","scope":"insider"},{"id":6190570,"accession":"0001645113-22-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000023","line_url":"/filing/0001645113-22-000023#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1094.0,"shares_display":"1,094","price_per_share":74.498,"price_display":"74.50","price_state":"stated","total_value":81500.812,"total_display":"81,500.81","shares_owned_after":66774.0,"shares_owned_after_display":"66,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-07","scope":"insider"},{"id":4110951,"accession":"0001645113-21-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000045","line_url":"/filing/0001645113-21-000045#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Restricted Share Units","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2404.0,"shares_display":"2,404","price_per_share":130.806,"price_display":"130.81","price_state":"stated","total_value":314457.624,"total_display":"314,457.62","shares_owned_after":67714.0,"shares_owned_after_display":"67,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-08","filed_date":"2021-03-10","scope":"insider"},{"id":5339868,"accession":"0001645113-21-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000039","line_url":"/filing/0001645113-21-000039#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Restricted Share Units","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3084.0,"shares_display":"3,084","price_per_share":137.554,"price_display":"137.55","price_state":"stated","total_value":424216.536,"total_display":"424,216.54","shares_owned_after":70118.0,"shares_owned_after_display":"70,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-04","filed_date":"2021-03-08","scope":"insider"},{"id":4533268,"accession":"0001645113-21-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-21-000026","line_url":"/filing/0001645113-21-000026#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Restricted Share Units","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2355.0,"shares_display":"2,355","price_per_share":152.053,"price_display":"152.05","price_state":"stated","total_value":358084.815,"total_display":"358,084.82","shares_owned_after":62860.0,"shares_owned_after_display":"62,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-04","scope":"insider"},{"id":4194771,"accession":"0001645113-21-000008","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-25","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11985.0,"shares_display":"11,985","price_per_share":171.903,"price_display":"171.90","price_state":"stated","total_value":2060257.455,"total_display":"2,060,257.46","shares_owned_after":71403.0,"shares_owned_after_display":"71,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194768,"accession":"0001645113-21-000008","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-24","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10110.0,"shares_display":"10,110","price_per_share":171.859,"price_display":"171.86","price_state":"stated","total_value":1737494.49,"total_display":"1,737,494.49","shares_owned_after":105156.0,"shares_owned_after_display":"105,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194765,"accession":"0001645113-21-000008","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-23","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4826.0,"shares_display":"4,826","price_per_share":171.318,"price_display":"171.32","price_state":"stated","total_value":826780.668,"total_display":"826,780.67","shares_owned_after":83388.0,"shares_owned_after_display":"83,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194762,"accession":"0001645113-21-000008","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-22","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":167.774,"price_display":"167.77","price_state":"stated","total_value":587209.0,"total_display":"587,209.00","shares_owned_after":92556.0,"shares_owned_after_display":"92,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194760,"accession":"0001645113-21-000008","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-21","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2841.0,"shares_display":"2,841","price_per_share":177.331,"price_display":"177.33","price_state":"stated","total_value":503797.371,"total_display":"503,797.37","shares_owned_after":61760.0,"shares_owned_after_display":"61,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194757,"accession":"0001645113-21-000008","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-20","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2761.0,"shares_display":"2,761","price_per_share":171.184,"price_display":"171.18","price_state":"stated","total_value":472639.024,"total_display":"472,639.02","shares_owned_after":115266.0,"shares_owned_after_display":"115,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194754,"accession":"0001645113-21-000008","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-19","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2542.0,"shares_display":"2,542","price_per_share":169.933,"price_display":"169.93","price_state":"stated","total_value":431969.686,"total_display":"431,969.69","shares_owned_after":88214.0,"shares_owned_after_display":"88,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194751,"accession":"0001645113-21-000008","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-18","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2502.0,"shares_display":"2,502","price_per_share":174.063,"price_display":"174.06","price_state":"stated","total_value":435505.626,"total_display":"435,505.63","shares_owned_after":67201.0,"shares_owned_after_display":"67,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194748,"accession":"0001645113-21-000008","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-17","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2499.0,"shares_display":"2,499","price_per_share":167.761,"price_display":"167.76","price_state":"stated","total_value":419234.739,"total_display":"419,234.74","shares_owned_after":120975.0,"shares_owned_after_display":"120,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194740,"accession":"0001645113-21-000008","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-16","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":177.305,"price_display":"177.30","price_state":"stated","total_value":390071.0,"total_display":"390,071.00","shares_owned_after":97956.0,"shares_owned_after_display":"97,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194737,"accession":"0001645113-21-000008","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-15","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":175.279,"price_display":"175.28","price_state":"stated","total_value":385613.8,"total_display":"385,613.80","shares_owned_after":65001.0,"shares_owned_after_display":"65,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194734,"accession":"0001645113-21-000008","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-14","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2148.0,"shares_display":"2,148","price_per_share":169.76,"price_display":"169.76","price_state":"stated","total_value":364644.48,"total_display":"364,644.48","shares_owned_after":118027.0,"shares_owned_after_display":"118,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194731,"accession":"0001645113-21-000008","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-13","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":169.194,"price_display":"169.19","price_state":"stated","total_value":304549.2,"total_display":"304,549.20","shares_owned_after":90756.0,"shares_owned_after_display":"90,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194730,"accession":"0001645113-21-000008","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-12","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":175.136,"price_display":"175.14","price_state":"stated","total_value":297731.2,"total_display":"297,731.20","shares_owned_after":100556.0,"shares_owned_after_display":"100,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194727,"accession":"0001645113-21-000008","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-11","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":173.1,"price_display":"173.10","price_state":"stated","total_value":294270.0,"total_display":"294,270.00","shares_owned_after":69703.0,"shares_owned_after_display":"69,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194724,"accession":"0001645113-21-000008","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-10","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":173.878,"price_display":"173.88","price_state":"stated","total_value":278204.8,"total_display":"278,204.80","shares_owned_after":102256.0,"shares_owned_after_display":"102,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194721,"accession":"0001645113-21-000008","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-9","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":172.952,"price_display":"172.95","price_state":"stated","total_value":224837.6,"total_display":"224,837.60","shares_owned_after":103856.0,"shares_owned_after_display":"103,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194718,"accession":"0001645113-21-000008","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-8","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":179.301,"price_display":"179.30","price_state":"stated","total_value":215161.2,"total_display":"215,161.20","shares_owned_after":59660.0,"shares_owned_after_display":"59,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194714,"accession":"0001645113-21-000008","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-7","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":178.675,"price_display":"178.68","price_state":"stated","total_value":178675.0,"total_display":"178,675.00","shares_owned_after":96956.0,"shares_owned_after_display":"96,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194708,"accession":"0001645113-21-000008","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-6","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":179.368,"price_display":"179.37","price_state":"stated","total_value":161431.2,"total_display":"161,431.20","shares_owned_after":96056.0,"shares_owned_after_display":"96,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194703,"accession":"0001645113-21-000008","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-5","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":178.498,"price_display":"178.50","price_state":"stated","total_value":160648.2,"total_display":"160,648.20","shares_owned_after":60860.0,"shares_owned_after_display":"60,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194702,"accession":"0001645113-21-000008","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-4","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":168.804,"price_display":"168.80","price_state":"stated","total_value":135043.2,"total_display":"135,043.20","shares_owned_after":120175.0,"shares_owned_after_display":"120,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194699,"accession":"0001645113-21-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-3","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":176.215,"price_display":"176.22","price_state":"stated","total_value":70486.0,"total_display":"70,486.00","shares_owned_after":64601.0,"shares_owned_after_display":"64,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":4194695,"accession":"0001645113-21-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-21-000008","line_url":"/filing/0001645113-21-000008#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":175.981,"price_display":"175.98","price_state":"stated","total_value":70392.4,"total_display":"70,392.40","shares_owned_after":100156.0,"shares_owned_after_display":"100,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":2835519,"accession":"0001645113-20-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-20-000047","line_url":"/filing/0001645113-20-000047#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Restricted Share Units","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2499.0,"shares_display":"2,499","price_per_share":69.534,"price_display":"69.53","price_state":"stated","total_value":173765.466,"total_display":"173,765.47","shares_owned_after":86753.0,"shares_owned_after_display":"86,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-06","filed_date":"2020-03-10","scope":"insider"},{"id":2766155,"accession":"0001645113-20-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-20-000030","line_url":"/filing/0001645113-20-000030#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2643.0,"shares_display":"2,643","price_per_share":72.215,"price_display":"72.22","price_state":"stated","total_value":190864.245,"total_display":"190,864.24","shares_owned_after":70032.0,"shares_owned_after_display":"70,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-28","filed_date":"2020-03-02","scope":"insider"},{"id":2158714,"accession":"0001645113-20-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-20-000013","line_url":"/filing/0001645113-20-000013#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8482.0,"shares_display":"8,482","price_per_share":81.156,"price_display":"81.16","price_state":"stated","total_value":688365.192,"total_display":"688,365.19","shares_owned_after":67119.0,"shares_owned_after_display":"67,119","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-25","filed_date":"2020-02-26","scope":"insider"},{"id":8068503,"accession":"0001209191-19-048481","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-20","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28340.0,"shares_display":"28,340","price_per_share":88.171,"price_display":"88.17","price_state":"stated","total_value":2498766.14,"total_display":"2,498,766.14","shares_owned_after":62816.0,"shares_owned_after_display":"62,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068497,"accession":"0001209191-19-048481","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-19","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24083.0,"shares_display":"24,083","price_per_share":88.215,"price_display":"88.22","price_state":"stated","total_value":2124481.845,"total_display":"2,124,481.84","shares_owned_after":65800.0,"shares_owned_after_display":"65,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068495,"accession":"0001209191-19-048481","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-18","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22264.0,"shares_display":"22,264","price_per_share":86.846,"price_display":"86.85","price_state":"stated","total_value":1933539.344,"total_display":"1,933,539.34","shares_owned_after":91156.0,"shares_owned_after_display":"91,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068491,"accession":"0001209191-19-048481","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-17","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20891.0,"shares_display":"20,891","price_per_share":86.954,"price_display":"86.95","price_state":"stated","total_value":1816556.014,"total_display":"1,816,556.01","shares_owned_after":89883.0,"shares_owned_after_display":"89,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068487,"accession":"0001209191-19-048481","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-16","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14888.0,"shares_display":"14,888","price_per_share":88.178,"price_display":"88.18","price_state":"stated","total_value":1312794.064,"total_display":"1,312,794.06","shares_owned_after":58000.0,"shares_owned_after_display":"58,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068484,"accession":"0001209191-19-048481","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-15","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11426.0,"shares_display":"11,426","price_per_share":86.858,"price_display":"86.86","price_state":"stated","total_value":992439.508,"total_display":"992,439.51","shares_owned_after":72888.0,"shares_owned_after_display":"72,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068481,"accession":"0001209191-19-048481","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-14","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7869.0,"shares_display":"7,869","price_per_share":88.973,"price_display":"88.97","price_state":"stated","total_value":700128.537,"total_display":"700,128.54","shares_owned_after":57931.0,"shares_owned_after_display":"57,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068477,"accession":"0001209191-19-048481","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-13","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6616.0,"shares_display":"6,616","price_per_share":88.818,"price_display":"88.82","price_state":"stated","total_value":587619.888,"total_display":"587,619.89","shares_owned_after":56200.0,"shares_owned_after_display":"56,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068473,"accession":"0001209191-19-048481","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-12","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6065.0,"shares_display":"6,065","price_per_share":88.194,"price_display":"88.19","price_state":"stated","total_value":534896.61,"total_display":"534,896.61","shares_owned_after":55229.0,"shares_owned_after_display":"55,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068470,"accession":"0001209191-19-048481","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-11","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4238.0,"shares_display":"4,238","price_per_share":86.882,"price_display":"86.88","price_state":"stated","total_value":368205.916,"total_display":"368,205.92","shares_owned_after":61294.0,"shares_owned_after_display":"61,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068466,"accession":"0001209191-19-048481","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-10","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4031.0,"shares_display":"4,031","price_per_share":89.869,"price_display":"89.87","price_state":"stated","total_value":362261.939,"total_display":"362,261.94","shares_owned_after":53900.0,"shares_owned_after_display":"53,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068462,"accession":"0001209191-19-048481","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-9","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2900.0,"shares_display":"2,900","price_per_share":88.863,"price_display":"88.86","price_state":"stated","total_value":257702.7,"total_display":"257,702.70","shares_owned_after":55100.0,"shares_owned_after_display":"55,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068459,"accession":"0001209191-19-048481","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-8","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":89.895,"price_display":"89.90","price_state":"stated","total_value":206758.5,"total_display":"206,758.50","shares_owned_after":53900.0,"shares_owned_after_display":"53,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068455,"accession":"0001209191-19-048481","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-7","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":89.857,"price_display":"89.86","price_state":"stated","total_value":107828.4,"total_display":"107,828.40","shares_owned_after":53900.0,"shares_owned_after_display":"53,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068447,"accession":"0001209191-19-048481","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-6","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":929.0,"shares_display":"929","price_per_share":88.937,"price_display":"88.94","price_state":"stated","total_value":82622.473,"total_display":"82,622.47","shares_owned_after":54300.0,"shares_owned_after_display":"54,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8068444,"accession":"0001209191-19-048481","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-048481","line_url":"/filing/0001209191-19-048481#line-5","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":89.969,"price_display":"89.97","price_state":"stated","total_value":35987.6,"total_display":"35,987.60","shares_owned_after":53900.0,"shares_owned_after_display":"53,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":7788140,"accession":"0001209191-19-014989","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-014989","line_url":"/filing/0001209191-19-014989#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001693530","owner_name":"Longsworth Todd Christopher","owner_url":"/insider/0001693530","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2368.0,"shares_display":"2,368","price_per_share":53.68,"price_display":"53.68","price_state":"stated","total_value":127114.24,"total_display":"127,114.24","shares_owned_after":36835.0,"shares_owned_after_display":"36,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-28","filed_date":"2019-03-01","scope":"insider"}],"next_cursor":"2019-02-28|7788140","ledger_fault":false,"count":{"value":57,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":57,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":57},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001645113","name":"NovoCure Ltd","url":"/issuer/0001645113","role":"Officer (General Counsel)","n_filings":17,"first_seen":"2018-01-31","last_seen":"2022-03-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001693530","retrieved_at":"2026-08-22T01:28:19+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}